Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Caracal – page 16

316 clinical trials in Caracal, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Caracal at a glance
316
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

316 trials in Caracal

Open in trial search

Neoplasm

Not recruiting

A Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:GSK4524101A
  • Sponsor:Glaxosmithkline Research & Development Limited

A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Eltrombopag
  • Sponsor:Novartis Pharma AG

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Breast cancer+1

Not recruiting

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Cholangiocarcinoma+7

Not recruiting

Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Amgen Inc.

Study of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Comparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Study comparing QL2107 and pembrolizumab in patients with resected non-small cell lung cancer receiving adjuvant therapy

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Qilu Pharmaceutical Co. Ltd.

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Adenocarcinoma gastric+3

Not recruiting

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Astellas Pharma Global Development Inc.

Chronic hepatitis C

Not recruiting

Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Bemnifosbuvir
  • Sponsor:Atea Pharmaceuticals Inc.

Cardiac failure

Not recruiting

Study on COR-1167 for Patients with Worsening Heart Failure

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:COR-1167 sodium
  • Sponsor:Corteria Pharmaceuticals

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Caracal

What the registry says about research in the country

01 Infectious Diseases

Clinical research focusing on influenza prevention in older adults, evaluating an advanced adjuvanted vaccine formulation compared to standard options. The studies aim to enhance immune response and provide better protection against various influenza strains.

  • Viral Disease Prevention
  • Elderly Population Health
  • Vaccine Efficacy

Research emphasizes the importance of improving vaccination strategies for vulnerable populations.

02 Cardiovascular Medicine

Groundbreaking research investigating novel treatments for atherosclerotic cardiovascular disease. Studies focus on preventing major adverse cardiovascular events through innovative therapeutic approaches targeting lipid management.

  • Cardiovascular Prevention
  • Lipid Management
  • Vascular Disease

The research aims to reduce cardiovascular mortality and improve patient outcomes.

03 Orthopedics & Pain Management

Innovative clinical trials exploring new treatments for knee osteoarthritis, focusing on novel therapeutic approaches for pain management. The research evaluates targeted interventions through intra-articular administration.

  • Joint Pain Management
  • Osteoarthritis Treatment
  • Local Therapeutic Delivery

Studies aim to provide better solutions for patients suffering from chronic joint pain.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.